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in bacterial pathogenicity: 
modulation of α-hemolysin from 
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Estibaliz Glaría3, Annabel F. Valledor3, Thomas V. O’Halloran2 & Carlos Balsalobre  1
Metal limitation is a common situation during infection and can have profound effects on the 
pathogen’s success. In this report, we examine the role of zinc limitation in the expression of a 
virulence factor in uropathogenic Escherichia coli. The pyelonephritis isolate J96 carries two hlyCABD 
operons that encode the RTX toxin α-hemolysin. While the coding regions of both operons are largely 
conserved, the upstream sequences, including the promoters, are unrelated. We show here that the 
two hlyCABD operons are differently regulated. The hlyII operon is efficiently silenced in the presence 
of zinc and highly expressed when zinc is limited. In contrast, the hlyI operon does not respond to zinc 
limitation. Genetic studies reveal that zinc-responsive regulation of the hlyII operon is controlled by 
the Zur metalloregulatory protein. A Zur binding site was identified in the promoter sequence of the 
hlyII operon, and we observe direct binding of Zur to this promoter region. Moreover, we find that Zur 
regulation of the hlyII operon modulates the ability of E. coli J96 to induce a cytotoxic response in host 
cell lines in culture. Our report constitutes the first description of the involvement of the zinc-sensing 
protein Zur in directly modulating the expression of a virulence factor in bacteria.
During infection, pathogens often encounter metal limitation. Alterations in the concentrations of certain metal 
ions have a great impact in cell physiology and gene expression. For instance, changes in the concentration of 
iron regulate the expression of virulence factors through metalloregulatory proteins such as Fur, the ferric uptake 
regulator, and the closely related PerR, the peroxide-stress regulator1,2. Recent studies revealed that another metal 
ion, zinc, also has an effect on bacterial physiology during infection3,4. Zinc is an essential element as a catalytic or 
structural cofactor of key enzymes and proteins involved in many processes such as DNA replication and protein 
synthesis and turnover5,6. Conversely, zinc can be toxic to bacteria when present in excess and so intracellular 
levels must be tightly controlled5,7. Zinc release from host tissue has been proposed to be an important innate 
defense mechanism7. In the case of S. pneumoniae infection in mice, elevated total zinc concentrations have been 
reported in host tissue and serum samples. The authors propose that the ability of zinc excess to inhibit pathogen 
growth arises from zinc competition with Mn uptake7. Zinc concentration in host fluids can rise in response to 
bacterial infection and inflammation by its release from damaged or apoptotic cells, and from sequestering pro-
teins such as metallothionein7.
Studies in both E. coli and B. subtilis have shown that, in response to variations in zinc concentration, cells 
regulate gene expression using the metalloregulatory protein Zur (zinc uptake regulator) as a sensor. Zur forms 
a dimeric complex with zinc acquiring the ability to bind DNA and to repress gene expression8. Characterized 
Zur regulons mainly consist of genes coding for proteins involved in zinc homeostasis and paralogs of ribosomal 
proteins which, under zinc limitation conditions, replace ribosomal proteins that contain zinc9. Although most 
known Zur-regulated genes are involved in zinc uptake and adaptation to low concentrations of the metal8–10, a 
number of questions about how Zur impacts overall cell physiology and pathogenesis remain unanswered.
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Uropathogenic Escherichia coli (UPEC) is the main causal agent of community-acquired urinary tract infec-
tions. In order to colonize its host, it expresses a battery of virulence factors including adhesins, siderophores, fla-
gella, and toxins11. One of these factors is the pore-forming toxin α-hemolysin, whose expression induces tissue 
damage and more severe infections12. Approximately 40–50% of UPEC isolates are able to produce α-hemolysin13. 
Remarkably, a recent study in mice linked zinc concentrations to the pathogenic effect of α-hemolysin during 
gastrointestinal disorders, showing that treatment with zinc protects against α-hemolysin-induced intestinal bar-
rier disfunction14.
α-hemolysin is encoded in the polycistronic operon hlyCABD, which contains four open reading 
frames (ORFs)15. The hlyC gene codes for an acyltransferase required for the activation of pro-α-hemolysin. 
Pro-α-hemolysin is encoded by hlyA, while the hlyB and hlyD genes encode two components of the secretory 
system that transports α-hemolysin out of the cells16,17. The hlyCABD operon in E. coli is tightly regulated and 
strongly affected by several environmental and physiological signals. A number of regulators, including RfaH, 
CpxRA and H-NS, modulate α-hemolysin expression18–21. In hemolytic UPEC isolates from humans, the hly-
CABD operon is present in the chromosome within pathogenicity islands, together with genes coding for other 
virulence factors22,23. Although most hemolytic UPEC strains carry a single copy of the operon, the presence of 
two functional copies of the hlyCABD operon has been detected in two pyelonephritis isolates, J96 and 53623.
In this article, we show that the two hemolytic operons present in the chromosome of E. coli J96 are differen-
tially regulated. The hlyI operon does not respond to zinc limiting conditions whereas the hlyII operon is silenced 
in the presence of zinc in a Zur-dependent manner. A highly conserved Zur binding site was found in the pro-
moter sequence of the hlyII operon. Direct binding of Zur to this promoter was confirmed by electrophoretic 
mobility shift assay (EMSA). Although a role of Zur-mediated regulation in bacterial pathogenicity has previously 
been suggested6,24, our research represents the first description of the involvement of zinc and the zinc-sensing 
transcription factor Zur in regulating the expression of a virulence factor in bacteria directly.
Results
The two hemolytic operons of J96 are differentially expressed. Two UPEC isolates, J96 and 536, 
extensively used as model organisms in pathogenicity studies, have two functional hlyCABD operons (designated 
I and II) coding for α-hemolysin (HlyA)23. The full sequences of the two operons from 536 and the hlyCABDII 
operon (hlyII) from J96 are known; however, only a fragment of the hlyCABDI operon (hlyI) from J96, carrying 
part of the hlyC gene (224 bp) and its upstream sequence, is available. While the ORFs of the sequenced operons 
are almost identical, the hlyC upstream sequences carrying the promoter and the regulatory motifs diverge exten-
sively between operons (Fig. 1a). Consistent with a previous report23, pairwise alignments showed two different 
types of sequence upstream of hlyC and indicated that the hlyII-J96 operon is identical to the hlyI-536 operon and that 
hlyI-J96 is identical to hlyII-536. The hlyII-J96 operon was the first hlyCABD operon cloned from human isolates and 
used to substantiate the contribution of HlyA to UPEC virulence25,26.
J96 derivative mutant strains carrying partial deletions of either hlyI or hlyII were obtained by gene replace-
ment. The hemolytic phenotype of the mutant derivatives was monitored on Columbia Blood Agar (CBA) plates 
(Fig. 1b). The mutant J96ΔII (ΔhlyII), carrying only the hlyI operon, displays a phenotype identical to the J96 
strain. However, the J96ΔI (ΔhlyI), carrying only the hlyII operon, exhibits a very thin hemolytic halo, suggesting 
that very little HlyA is produced from hlyII operon under optimal conditions for HlyA detection27. The levels of 
secreted HlyA by J96 and its derivatives J96ΔI and J96ΔII were determined in bacterial cultures grown in LB0 
(with no NaCl added) at 37 °C up to late-logarithmic phase. SDS-PAGE separation of secreted protein extracts 
from J96 revealed a single band at 110 kDa, corresponding to HlyA. Consistent with the hemolytic phenotype, the 
amount of HlyA secreted by the J96ΔII strain (hlyI operon) was very similar to the amount detected in the extract 
from the wild-type strain, whereas the amount of HlyA secreted by the J96ΔI strain (hlyII operon) was much 
lower (Fig. 1c). These results suggest that in the assessed experimental conditions, the hlyI operon is the main 
contributor to the HlyA production and the hlyII operon is somehow silenced. The extracts analyzed in Fig. 1c 
were obtained from cultures grown in LB0, however, the described differential expression of the two hly operons 
of J96 does not depend on the external osmolarity. Secreted protein extracts from cultures grown in LB (5 g l−1 
of NaCl) were also analyzed. Although expression of HlyA was lower in all the strains, hlyI expressed most of the 
HlyA, while expression of HlyA from the hlyII operon was barely detected (Fig. S1).
A mutation in zur, encoding the zinc uptake regulator, causes derepression of the hlyII 
operon. To identify putative regulators of the hlyII operon responsible for its low expression under the assessed 
conditions, random mutagenesis using a gentamycin resistance mariner transposon was performed on strain 
JFV3, a J96 derivative that carries a chromosomal hlyII::lacZ reporter fusion. Mutants were selected according to 
their Lac phenotype on LB agar plates with X-gal, to detect hlyII::lacZ expression. The clone #13 was selected for 
its deep blue colour compared to the parental strain, which indicates increased expression of hlyII::lacZ (Fig. 2a). 
Quantitative expression studies showed that the selected GmR mutant causes a drastic derepression (47-fold) of 
the hlyII operon transcriptional expression (Fig. 2b). Using primers for the mariner transposon, the nucleotide 
sequence adjacent to the insertion was determined in clone #13. The transposon was inserted within the zur gene, 
in codon 142 of 172.
The zur gene encodes the Zur protein (zinc uptake regulator), a transcriptional repressor that binds to DNA 
in the presence of zinc and thereby represses specific genes28. To corroborate the association of Zur with the 
observed derepression, a new zur mutant was generated in J96 by gene replacement. The sequence of the zur gene 
between positions 43 and 381 bp (position 1 corresponds to the first nucleotide of the first codon) was deleted, 
and a CmR cassette was inserted. The zur::CmR allele causes the same effect on hlyII transcriptional expression as 
the GmR allele obtained by random mutagenesis both in late-logarithmic phase (Fig. 2b) and in mid-logarithmic 
phase (Fig. S2) of bacterial growth. The effect of the zur mutation on hlyII expression was also determined by 
www.nature.com/scientificreports/
3SCIeNtIfIC REPORTS |  (2018) 8:6535  | DOI:10.1038/s41598-018-24964-1
measuring the amount of the secreted HlyA in culture supernatants of Zur proficient and deficient derivatives of 
J96, J96ΔI and J96ΔII strains. Both Coomassie-staining and immunodetection using specific HlyA antibodies 
showed a clear increase in the amount of HlyA in the presence of the Δzur mutation in the two strains carrying 
the hlyII operon (J96 and J96ΔI) (Fig. 2c). By contrast, derepression of the hlyI operon (J96ΔII strain) was not 
detected in the zur mutant (Fig. 2c and Fig. S1). Due to the low expression level of the hlyI operon in LB, HlyA 
immunodetection in J96ΔII extracts was performed on 20-fold concentrated samples. Furthermore, the sever-
ity of the hemolytic phenotype correlates with the amount of HlyA in each strain. The strain carrying only the 
operon hlyII showed minimal hemolysis in the presence of an intact zur gene and a higher hemolytic phenotype 
when the zur gene was mutated. Strains carrying only the hlyI operon showed the same phenotype, regardless of 
the presence or absence of an intact zur gene (Fig. 2d). These results clearly indicate that Zur specifically regulates 
the hlyII operon. Zur-mediated regulation of hlyII transcription was confirmed by trans-complementation exper-
iments (Fig. 2b). The strong derepression of the hlyII operon observed in the zur mutant was fully complemented 
when a pBR322 derived plasmid containing the J96 zur gene with its own promoter was introduced in the mutant 
strain. Our findings on the Zur-mediated regulation of the hlyII operon of J96 are the first description of a regula-
tory factor that modulates differently the two hemolytic operons present in J96.
Hemolysin has a role in cell toxicity and urothelial damage during infection19,29. In order to determine the 
impact of Zur-mediated regulation of α-hemolysin on bacterial pathogenicity, we assessed the ability of different 
derivatives of the J96 strain to induce hemoglobin release after infection of blood cell suspensions and cell detach-
ment after infection of bladder epithelial cell monolayers. A slight increase in hemolytic activity was detected after 
infection of the Δzur derivatives of J96 and J96ΔII as compared to the zur+ counterparts (Fig. 3A). Remarkably, 
the zur mutation caused a very drastic effect when blood cell suspensions were infected with derivatives of the 
J96ΔI strain. Hemolytic activity was more than 12-fold higher in the Δzur mutant as compared to wild-type 
strain, consistent with the described derepression of the hlyII operon in strains lacking Zur. As a control, J96 deriv-
ative strains lacking both hlyI and hlyII operons showed very low hemolysis in either zur+ or Δzur background. 
These results clearly demonstrate that the effect observed was caused by α-hemolysin.
Next, we performed infection assays of bladder epithelial cells (T24 monolayers) using the same bacterial 
strains (Fig. 3B). After 3.5 hours of infection with the J96ΔI strain, the monolayers were intact, showing a per-
centage of attached cells similar to the uninfected monolayers. In contrast, when monolayers were infected 
with the Δzur derivative of J96ΔI less than 20% of the cells remained attached after 3.5 hours. Again, the 
Figure 1. Differential expression of the two hlyCABD operons present in the J96 strain. (a) Percentage of 
identity at the level of the nucleotide sequence between the operon hlyI and hlyII of J96 and 536. n.d.: not 
determined. (b) Hemolytic phenotype of J96, JFV16 (J96ΔII) and JFV21 (J96ΔI) strains on Columbia Blood 
agar plates. (c) Coomassie blue stained SDS-PAGE (10%) of secreted protein extracts from cultures grown in 
LB0 at 37 °C up to late-log phase (OD600 nm of 1.0) of the indicated strains. Lane M: molecular mass markers 
(size in kDa indicated along the left side). The band corresponding to α-hemolysin (HlyA) is indicated with an 
arrowhead. Full-length gel image is shown in Fig. S6.
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effect can be attributed to the production of α-hemolysin since cell attachment did not decrease after infec-
tion with J96ΔIΔIIΔzur. The specific effect of α-hemolysin production on cell monolayers could be detected 
2 hours post-infection as cells became round-shaped when infected with strain J96ΔIΔzur (Fig. 3C), an 
α-hemolysin-induced phenotype previously described30. Both wild-type and Δzur derivatives of the J96 
and J96ΔII strains, carrying the Zur-independent hlyI operon, disrupt cell adhesion at different extents 
(Fig. 3B). In line with the aforementioned expression studies on the hlyII operon, the Δzur mutation triggers 
virulence-associated features such as hemoglobin release and disruption of epithelial cell adhesion.
Expression of the hlyII operon responds to the presence of zinc. In the presence of zinc, the tran-
scriptional regulator Zur forms a complex that binds to DNA, causing transcriptional repression8. We hypoth-
esized that the hlyII operon should be repressed by the presence of zinc in a Zur-dependent manner. To test this 
hypothesis, transcriptional expression of the hlyII operon was monitored in cultures of strain JFV3 grown in either 
LB depleted from zinc (M-LB) or the same medium replenished with 1 μM and 10 μM ZnCl2. In the zur+ strain, 
hlyII transcriptional expression is high in the absence of zinc and severely drops in medium replenished with 
this metal ion (Fig. 4a). Remarkably, the response of hlyII expression to zinc was dose-dependent. Furthermore, 
zinc-mediated regulation is strictly dependent on the presence of Zur, since no repression is observed in a zur 
mutant strain by the presence of zinc. The growth kinetics of the JFV3 strain was not altered by the absence or 
presence of different zinc concentrations (Fig. 4b). The effect of zinc on hlyII transcriptional expression was cor-
roborated by monitoring the level of secreted HlyA. In cultures of the strain J96ΔI, a high amount of secreted 
HlyA was detected in the absence of zinc, whereas the HlyA amount was very low in cultures grown in the pres-
ence of ZnCl2 (10 μM) (Fig. 4c). The amount of secreted HlyA from hlyI operon was also monitored in both the 
absence and presence of zinc. Consistent with the fact that hlyI operon expression was not altered by the zur muta-
tion, the expression of hlyI operon was not affected by the presence of zinc. In cultures of the J96 strain, carrying 
both hlyI and hlyII operons, a slight effect on HlyA production by the presence of zinc was detected.
Zur directly represses hlyII expression by binding to its promoter. The effect of sudden addition 
of ZnCl2 (10 μM) on hlyII transcriptional expression was monitored in cultures of strains JFV3 and its ∆zur 
Figure 2. Expression of the hlyII operon of J96 is derepressed by a mutation in the zur gene. (a) Lac-phenotype 
on LB Xgal agar plates of the JFV3 (J96 hlyII::lacZ) strain and its GmR derivative (clone #13) obtained by 
random mutagenesis. Below is represented the location of the GmR transposon insertion in clone #13. (b) 
Transcriptional expression of the hlyII operon from cultures of the JFV3 strain and the two derivatives zur::GmR 
(clone #13) and zur::CmR (EV46) grown in LB at 37 °C up to late-log phase (OD600 nm of 1.0). β-Galactosidase 
activity (Miller units) was determined in three independent cultures. Mean values with standard deviations 
are plotted. *P < 0.05, ANOVA with Tukey’s multiple comparisons test. (c) Electrophoretic analysis of secreted 
protein extracts from cultures grown in LB at 37 °C up to late-log phase of J96, JFV16 (J96ΔII) and JFV21 
(J96ΔI) strains and their otherwise isogenic zur::CmR mutants (EV27, EV34 and EV38, respectively). Upper 
panels are Coomassie blue stained 10% SDS-PAGE and lower panels immunodetection using monoclonal 
anti-HlyA antibody. Samples for immunodetection from J96ΔII were concentrated 20x with respect to rest of 
samples for better visualization. Full-length gel and blot images are shown in Fig. S7. (d) Hemolytic phenotype 
of JFV16 (J96ΔII) and JFV21 (J96ΔI) strains and its zur mutant derivatives on Columbia Blood agar plates.
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derivative grown in M-LB medium up to an OD600 nm of 0.3. Bacterial growth was not substantially affected by 
adding ZnCl2 (10 μM) to the zinc-free medium cultures (Fig. 5a). The ZnCl2 exposure caused a rapid decrease of 
the hlyII transcriptional expression in the Zur proficient strain, as compared to cultures where no ZnCl2 was added 
(Fig. 5b). After 15 minutes, a drop in hlyII expression was already detected, falling to 53% of the levels measured 
in cultures grown with no ZnCl2 addition. Expression progressively declined to 20% after one hour exposition to 
ZnCl2. In agreement with all previous results, exposure to ZnCl2 during one hour did not significantly alter the 
expression of the hlyII operon in a zur mutant strain. As a control, the level of hlyII operon expression was very low 
in cultures grown in M-LB replenished with ZnCl2 from the start.
Figure 3. Effect of zur mutation in UPEC virulence-associated phenotypes. (A) Hemolysis after 1 hour 
infection of sheep blood cell suspensions with J96, JFV21 (J96ΔI), JFV16 (J96ΔII) and EV64 (J96ΔIΔII) 
strains and their otherwise isogenic zur mutants (EV27, EV34, EV38 and EV65). The release of haemoglobin 
was monitored by OD545 nm. (B) T24 cell monolayer detachment activity. Percentage of remaining attached T24 
cells, measured as OD590 nm, after 3.5 h post-infection with the same strains as in (A) Mean values with standard 
deviation from three independent experiments (A) and three biological replicates (B) are plotted. *P < 0.05 
**P < 0.0001 n.s.: non-significant, t test with p-values adjusted by Bonferroni’s method (C) Phase contrast 
microscopy of T24 bladder epithelial cell monolayers infected for 2 hours with the indicated strains. Scale bar, 
0.1 mm.
Figure 4. The expression of the hlyII operon of J96 responds to the external levels of zinc. (a) Transcriptional 
expression from the hlyII promoter in cultures of the strains JFV3 and its zur::CmR mutant derivative (EV46) 
grown in M-LB and M-LB replenished with either 1 or 10 μM ZnCl2. Culture samples were taken at late-log 
growth phase (OD600 nm of 1.0). β-galactosidase activity (expressed in Miller units) was determined from 
three independent cultures; mean values with standard deviation are plotted. *P < 0.05, ANOVA with Tukey’s 
multiple comparisons test (b) Growth curves of JFV3 strain cultured in M-LB and in M-LB replenished with 
10 μM ZnCl2. Growth was monitored by measuring OD600 nm from two independent cultures; mean values are 
plotted.(c) Detection of the α-hemolysin in secreted protein extracts from cultures of J96, JFV21 (J96ΔI) and 
JFV16 (J96ΔII) strains and their otherwise isogenic zur mutants (EV27, EV34 and EV38) grown in M-LB and 
M-LB replenished with 10 μM ZnCl2. Full-length gel images are shown in Fig. S8.
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The fast response to ZnCl2 of hlyII transcriptional expression suggested that Zur directly represses the hlyII pro-
moter. Zur regulates transcription by cooperative binding of two dimers to a well-characterized DNA sequence 
located in the vicinity of the promoter of Zur-regulated genes9,31. Using the consensus sequence reported31 for 
the E. coli Zur box (RNNNYRNNRYNNYRNNNY), the J96 hlyII promoter sequence was scrutinized, revealing a 
putative Zur binding site (Fig. 6a and b). The bases of the Zur box involved in establishing hydrogen-bonds with 
Zur have been identified31 and are indicated in Fig. 6b. The motif found in the J96 hlyII promoter sequence was 
highly conserved except for the base G19′ (see Fig. S3). It must be noted that G19′ is one of the least determinant 
bases for Zur binding31.
Figure 5. Rapid response of hlyII transcriptional expression to zinc addition. (a) Growth curves of the strain 
JFV3 and EV46 (zur::CmR) in the indicated media by measuring OD600 nm from two independent cultures; 
mean values are plotted. (b) Transcriptional expression of hlyII in cultures of JFV3 and EV46 after zinc addition. 
Cultures were grown in M-LB up to an OD600 nm of 0.3 when media was either replenished or not with 10 μM 
ZnCl2. Culture samples were taken right before ZnCl2 addition (0 minutes), and after 15, 30 and 60 minutes. 
As a control, JFV3 was cultured in M-LB replenished with 10 μM ZnCl2 from the beginning. β-galactosidase 
activity (expressed in Miller units) was determined from three independent cultures; mean values with standard 
deviation are plotted.
Figure 6. Zur protein binds to the hlyII promoter. (a) Sequence of the hlyII operon upstream of hlyC. In bold are 
indicated the first codon (ATG) of hlyC and the putative −10 and −35 boxes of the promoter. Within the blue 
box is indicated the putative binding site of Zur. The red box indicates the transcriptional start found by 5′RACE 
assays. (b) Sequence of the putative Zur binding site found in the hlyII operon promoter. Bases recognized by 
Zur dimers are colored: green for conserved bases and red for the only base that is not conserved. A dashed line 
represents the symmetry axis. Below are depicted the positions of Zur binding sites in promoters of znuABC, 
zinT, rpmE29 and hlyII. Zur boxes were drawn to scale in respect of transcription start site. (c) Sequence of the 
5′RACE assay using J96 total RNA samples grown in LB at 37 °C up to late log phase. The two bases identified 
as a transcriptional start are indicated with arrowheads. The N residue corresponds to a mix of A and C bases. 
(d) Electrophoretic mobility shift assay. Titration of a Cy5 labeled 50-bp hlyII promoter fragment carrying 
the putative Zur binding site was carried out in the presence of excess salmon sperm DNA which serves as 
a non-specific competitor. Samples contains 60 pM DNA, plus 0, 15, 30, 50, 100, 150, 200, 300, 350, 900 pM 
Zur (calculated as dimer), respectively. Samples were resolved on a 10% polyacrylamide gel. Both gel and 
electrophoresis buffers contain 50 µM ZnSO4. Full-length gel image is shown in Fig. S9.
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A transcriptional start for the hlyII operon was previously proposed based on primer extension analyses on 
RNA samples from K12 strains carrying the hlyII operon in a multicopy plasmid32. In our study, 5′-RACE with 
RNA samples from J96 was performed and a hlyII operon transcription start was defined 9 nucleotides upstream 
of the previously described +1 position. This transcriptional start site is properly positioned to a putative pro-
moter identified with the Neural Network Promoter Prediction software (Fig. 6a and c). Consequently, the puta-
tive Zur binding site is located at positions −25 to −6. Zur binding would overlap the −10 sequence, blocking the 
binding of RNA polymerase and repressing hlyII transcription. The relative position of the putative Zur binding 
site found in the hlyII operon and other genes of the E. coli Zur regulon was compared after searching the Zur 
consensus sequence described31 within the upstream regions of Zur-regulated genes9. The relative location of 
the putative Zur binding site in the hlyII operon turned out to resemble the position of other members of the 
Zur regulon (Fig. 6b). For instance, the location of the Zur box in znuC and zinT is −22 to −3 and −23 to −4, 
respectively.
The ability of Zur to bind to the hlyII promoter sequences in vitro was assessed using EMSA. The Zur protein 
used in this assay is derived from the E. coli strain MG1655, which shares 97.7% identity and 100% similarity 
with the Zur protein from J96. The results clearly demonstrate that Zur binds the hlyII promoter in vitro (Fig. 6d). 
Remarkably, E. coli Zur binds to the hlyII operon even more tightly than it does to the E. coli MG1655 Zur pro-
moter region for the L31p promoter (0.025 ± 0.01 × 10−18 M2), which corresponds to the highest affinity of any 
of the operator sites evaluated31. While the binding is too tight to calculate a reliable dissociation constant under 
these experimental conditions, the Zur concentration at half maximal binding (100 nM Zur dimer) allow us to 
estimate an upper limit for this dissociation constant, i.e. <0.02 × 10−18 M2. Together with the in vivo studies on 
gene expression, these data reveal that Zur likely represses transcription of the hlyII operon directly and confirm 
that the hlyII operon is part of the Zur regulon in the UPEC strain J96. Interestingly, the putative Zur binding 
site was also found in the hlyI operon from the UPEC strain 536 that is equivalent to hlyII from J96. In 536 two 
mismatches from the consensus sequence were found: the mismatch already found in J96 hlyII and a second base 
which does not directly interact with Zur (in position 13, a G instead of A or T is found). The upstream intergenic 
sequence of the hlyI operon of J96 was also analyzed for a Zur binding site and, as expected, none was found. No 
Zur binding sites were found in upstream intergenic regions of hly operons from other UPEC isolates such as 
CFT073, UTI89 and F11. Pairwise alignments showed that these operons and their promoters are J96 hlyI-like. 
Accordingly, the Δzur mutation in CFT073 does not cause an increase of HlyA production and hemolysis after 
infection of blood cells (Fig. S4).
Discussion
The presence of two hlyCABD operons in the UPEC isolates J96 and 536, with more than 7 Kb DNA sequence 
sharing 99% identity, is intriguing considering that the presence of large homologous DNA sequences in a chro-
mosome may cause genome instability and result in detrimental effects on bacterial fitness. Interestingly, the 
sequences upstream of the hlyC gene from both operons differ greatly, indicating that their regulatory sequences 
are unrelated and suggesting the existence of different mechanisms of regulation. Indeed, in this report we 
demonstrate that the hlyII operon is silenced by the Zur regulator allowing expression only under zinc limiting 
conditions. In contrast, the operon hlyI does not respond either to zinc or this regulator (Zur). Interestingly, most 
hlyCABD operons from human isolates described in databases showed homology to the Zur-insensitive operon 
hlyI, whereas the hlyII operon was only detected in two pyelonephritis isolates, 536 and J96, and in the environ-
mental isolate MRE600. Recent genomic and phylogenetic studies revealed that MRE600 is an E. coli strain with 
distinctive genomic properties and more similar to Shigella than to other E. coli strains33.
One may hypothesize that expressing hemolysin under a wide variety of environmental conditions, including 
zinc limitation, may be beneficial to ensure success during the process of host colonization. In this scenario, the 
versatility provided by having two operons that respond to different conditions may constitute an adaptive advan-
tage that outweighs the detrimental effect in fitness caused by genome instability due to the coexistence of large 
and highly homologous DNA sequences.
Previous studies suggest that zinc may play a relevant role during host colonization since zinc uptake systems 
are important for fitness in different pathogens, including UPEC6,34. However, the exact role of the Zur protein in 
the control of virulence factors has not yet been elucidated35. In S. aureus, Zur does not have an apparent role in 
pathogenicity, as concluded from assays using an in vivo infection model36. In M. tuberculosis and S. suis, Zur reg-
ulates genes coding for proteins belonging to the early secretory antigen target and metalloproteases, respectively, 
although the role of those proteins in virulence is unclear37,38. In A. baumannii, the zur mutant exhibits a defect in 
dissemination in a pneumonia mouse model, and RNA-seq assays showed that several genes encoding secreted 
proteins and putative virulence factors were upregulated in the mutant strain24. Our study is the first description 
of a direct Zur-mediated regulation of the expression of a virulence factor, UPEC’s α-hemolysin. More precisely, 
Zur represses the transcriptional expression of the hlyII operon of J96, which consequently is only expressed under 
zinc limiting conditions. This finding raises thought-provoking questions. Is α-hemolysin expression a mecha-
nism used by the bacterium to release or mobilize zinc from cells? If so, this may facilitate growth of bacterial 
pathogens in spite of host-induced zinc limitation. In this scenario, hlyII expression would be acting as a bacterial 
factor involved in zinc homeostasis. Is the response of the J96 hlyII operon to zinc, and therefore the acquisition 
of the Zur box, required for proper sensing of specific environments? If so, the presence of hlyII may facilitate 
efficient colonization of sites within the host.
As exemplified by iron, metal limitation is a common situation during host-pathogen interactions1. Zinc 
concentration in most human tissues is extremely low39. Within the cytosol of human cells available zinc is 
particularly scarce, due to its sequestration by metallothioneins40. Furthermore, during infection phagocytes 
and epithelial cells express other zinc-chelating proteins, such as calprotectin41–43. In the case of UPEC, which 
invades the urinary tract, it inevitably faces zinc-limiting conditions since zinc concentration in human urine 
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was reported to range between 0.17 and 0.5 ppm (2.6 to 7.6 µM) in healthy subjects, being one of the human 
corporal fluids with lowest zinc concentration reported39,44,45. Furthermore, UPEC probably encounters zinc star-
vation during intracellular growth, where bioavailable zinc is limited due to sequestration by host proteins like 
metallothioneins.
On the other hand, zinc concentration in the intestine, the reservoir of UPEC, is considerably high, due to 
the predominant fecal excretion of this metal46. One may speculate that during intestinal transit hlyII expression 
would be repressed by Zur, and therefore very little HlyA would be produced from this operon. Interestingly, 
during acute gut inflammation, calprotectin released by neutrophils sequesters zinc and, during this zinc-limiting 
conditions, Salmonella enterica Typhimurium grows better than gut commensal bacteria due to increased expres-
sion of the Zur-regulated ZnuABC transporter3. Moreover, anomalously high expression of hlyA by the UPEC 
isolate 536 in the intestine has been detected during active ulcerative colitis, which produces acute inflamma-
tion47. Therefore, it is reasonable to hypothesize that intestinal zinc limitation due to inflammation could promote 
the production of HlyA by UPEC strains residing in the gut and carrying hemolytic operons responsive to zinc, 
thus producing further inflammatory lesions in ulcerative colitis. A recent report described zinc treatment to be 
efficient against α-hemolysin-induced intestinal leakage in mice colonized by the pyelonephritis isolate 53614. It 
is known that zinc is an important factor for intestinal barrier integrity48. Although the authors showed that zinc 
has a protective effect on α-hemolysin-mediated damage per se, our data indicate that zinc may have an additional 
protective effect by promoting downregulation of α-hemolysin expression from the 536 strain, which contains 
a homolog of the Zur-regulated operon here reported. Our study describes the direct involvement of Zur in the 
control of virulence expression and suggests that zinc limitation may play a pivotal signaling role during the 
infectious process.
Methods
Bacterial strains, plasmids and growth conditions. Bacterial strains used in this work, shown in 
Table 1, are all derived from the pathogenic isolates J96 and CFT073. All strains were grown routinely in LB 
(Lennox broth, tryptone 10 g l−1, yeast extract 5 g l−1 and NaCl 5 g l−1) at 37 °C with aeration. LB without NaCl 
and with 10 g l−1 of NaCl was used and denoted LB0 and LB10, respectively. In most experiments, bacterial cul-
tures were grown up to an OD600 nm of 1.0, denoted late-log phase of growth. The zinc-free medium (M-LB) was 
prepared as indicated49. Briefly, LB medium was treated with 50 mg l−1 of chelating resin Chelex 100 (Bio-Rad) 
one hour at room temperature while stirring. After removing the resin by filtration (0.2 μm), trace elements were 
replenished by adding 1 μM FeCl3, 1 μM CaCl2, 20 μM MgCl2 and 1 ml l−1 SL-7 trace element solution (without 
zinc). Finally, 20 μM TPEN (N,N,N′,N′-Tetrakis(2-pyridylmethyl)ethylenediamine, Sigma-Aldrich) was added 
to further chelate zinc. Replenishment solutions were prepared out of concentrated stock solutions and sterilized 
by filtration using 0.2 μm filters when necessary. SL-7 trace element solution without zinc has the following 
composition: 10 ml 25% HCl, 1.5 g FeCl2·4H2O, 190 mg CoCl2·6H2O, 100 mg MnCl2·4H2O, 63 mg H3BO3, 36 mg 
Na2MoO4·2H2O, 24 mg NiCl2·6H2O, 17 mg CuCl2·2H2O and deionized water to a final volume of 1 L. In order to 
minimize contamination by zinc, all cultures with M-LB were performed in 5 ml culture medium using 50 ml 
conic centrifuge plastic tubes. Any other used material was also made of plastic and handled so as to avoid metal 
contamination. To monitor hemolytic phenotype Columbia Blood Agar plates (Scharlau) were used.
When needed, antibiotics were added to culture media at the indicated concentrations: kanamycin 
(50 μg ml−1), ampicillin (50 μg ml−1), chloramphenicol (25 μg ml−1) and gentamycin (10 μg ml−1). X-gal (5-bromo-
4-chloro-3-indoyl-β-D-galactopyranoside) was added to the medium at 40 μg ml−1.
Genetic techniques. The primers used in this work are listed in Table S1 (supplementary material). The 
strain J96Δlac is a ΔlacZ derivative of J96 strain obtained as previously described50. The strain JFV16 (J96ΔII), 
carrying a hlyA deletion from codon 20 to 434 was constructed using the primers HlyA-P1 and HlyA-P2 and the 







JFV3 JFV23 hlyA::lacZ KmR




EV64 J96 ΔhlyII ΔhlyI:: CmR
EV65 J96 ΔhlyII ΔhlyI:: CmR Δzur::KmR
CFT073 Pathogenic isolate
DJ1 CFT073 Δzur::CmR
Table 1. Strains used in this work.
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to the codon 422 of hlyA was constructed using the same methodology and the primers Hly1-P1 and Hly1-P2-2. 
Strain EV64 (J96ΔIΔII) was obtained using the same methodology and the primers Hly1-P1 and Hly1-P2-2 on 
the JFV16 strain. Similarly, zur mutants were generated using primers ZurP1 and ZurP2.2 in J96 and ZurP1.2 and 
ZurP2.1 in CFT073. The strain JFV3 carries a promoter less lacZ gene linked to a kanamycin resistance cassette 
inserted in the hlyA gene of the hlyII operon. The lacZ-KmR cassette from plasmid pKG137 was inserted into the 
hlyA gene of JFV16 following the method described previously52. The zur gene of J96 together with the intergenic 
region located upstream of the zur ORF was PCR-amplified using the primers Zur-BamHI and Zur-EcoRI. The 
PCR-amplified fragment was cloned in pBR322 resulting the plasmid pBRzur.
SDS-PAGE and Western immunoblotting analyses. The standard SDS-PAGE procedure was used 
to monitor HlyA production. Gels were routinely stained with Coomassie blue. For immunoblotting, proteins 
were transferred to PVDF membranes and detected with the monoclonal anti-α-hemolysin H1053 and a horse-
radish peroxidase-conjugate antibody (Promega) using the ECL Plus Western Blotting Detection System (GE 
Healthcare). Gels were analyzed on a Chemidoc System (BioRad) equipped with the QuantityOne® Software.
β-Galactosidase assay. β-Galactosidase activity was monitored by the method described earlier54. Data 
shown are mean values and standard deviation of duplicate determinations from three independent experiments.
Assay of hemolytic activity. Quantitative hemolytic assay was performed essentially as previously 
described55. Briefly, a 10% defibrinated sheep blood suspension was prepared in 0.9% NaCl containing 10 mM 
CaCl2, centrifuged and resuspended in the same volume of the same solution. The wash step was repeated three 
times in order to eliminate debris from broken cells. Bacterial cultures were grown in LB10 at 37 °C to an OD600 nm 
of 1.0, centrifuged to discard supernatant and the bacterial pellet resuspended in the same volume of LB10. In 
96-well microtiter plates 50 µl of blood suspension was mixed with an equal amount of a 1/125 dilution of the 
bacterial cell suspension, centrifuged (400 g, 10 min, 4 °C) and incubated for 60 min at 37 °C. Thereafter, 100 µl of 
ice-cold 0.9% NaCl was added and the microtiter plate was centrifuged (400 g, 10 min, 4 °C). A 100 µl aliquot of 
the supernatant was removed to another plate and the release of haemoglobin measured spectrophotometrically 
at 545 nm. In all plates non-infected wells were used as controls and the resulting OD545 nm from those controls 
was subtracted to the value obtained for the different samples. A bar shows the arithmetic mean of experimental 
results and the error bar indicates the standard deviation from three independent experiments. Control experi-
ments using blood suspension prepared in 0.9% NaCl, in the absence of CaCl2, were performed. Consistent with 
the fact that the activity of hemolysin is calcium-dependent no hemoglobin release was detected. LB10 was used 
since regular LB (5 g/L NaCl) causes unspecific release of haemoglobin due to osmotic pressure alterations.
T24 cell culture assays. T24 bladder epithelial cells were maintained in RPMI supplemented with 10% 
heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin. Bacterial cultures were grown in LB 
at 37 °C. Infection assays were performed in 24-well plates containing RPMI- 10% FBS where 10 µL of bacterial 
growth (OD600 nm of 0.5) were added to a monolayer of T24 cells. After infection, the cells were incubated at 37 °C, 
5% CO2 for 2 h for microscopy analysis and for 3.5 h for measurements of cell detachment. The T24 monolayers 
were visualized after 2.5 h with an Axiovert 40 C inverted optical microscope (Carl Zeiss) and images were cap-
tured with EOS 1000D Canon camera at 25X increase. After 3.5 h infection, the cells were washed three times 
with ice-cold PBS, fixed in 10% formalin for 15 min at room temperature and stained in 0.1% Crystal Violet, 
0.2% ethanol for 10 min at room temperature. After 2 washes with water, the cells were allowed to dry at room 
temperature and then lysed in 2% sodium dodecyl sulphate (SDS) for 30 min. The absorbance was quantified by 
spectrophotometry at 590 nm as an indicator of crystal violet staining. The data is given as percentage of attached 
cells. For each experiment the OD590 nm of non-infected samples was given arbitrarily the value 100%. A bar 
shows the arithmetic mean of experimental results and the error bar indicates the standard deviation from three 
biological replicates.
Random mutagenesis with pBT20 plasmid. Mutagenesis experiments were performed using the 
mariner-based transposon system carried on plasmid pBT2056. Bacterial suspensions of the donor (E. coli 
S17-λpir containing pBT20) and the recipient (JFV3) were recovered from overnight plates and resuspended 
in LB. These suspensions were adjusted to OD600 nm of 40 and 20, respectively, and mixed in a 1:1 ratio. Aliquots 
of 50 μl were spotted on a LB agar plate and incubated at 37 °C for 6 h. The mating mixtures were subsequently 
recovered in LB and cultured on LB agar plates containing kanamycin, gentamicin, and X-gal at 37 °C. Clones 
depicting darker blue color were selected, and hlyII transcriptional expression was monitored by β-galactosidase 
quantification. Clone #13 genomic DNA was extracted using the Blood & Cell Culture DNA Midi kit (Qiagen) 
with the Genome DNA Buffer Set (Qiagen) and sequenced using the primer 526.
5′RACE assay. The 5′ end of the hlyII operon transcript was determined using the 5′ RACE System for Rapid 
Amplification of cDNA Ends (Invitrogen). Total RNA was isolated from cultures of the J96 strain grown in LB 
at 37 °C up to an OD600 nm of 1.0. Retrotranscription was done using the oligo hlyIIBamIII, specific for the hlyII 
operon. Next, a polyC tail was added to the 3′ end of the cDNA by using terminal deoxynucleotidyl transferase. 
Two rounds of PCR amplification were performed using specific primers for the hlyII operon, hlyII-GSP2 and 
hlyII-GSP3, and primers provided by the commercial kit. The final PCR product was isolated and sequenced.
Electrophoretic Mobility Shift Assay. Zur binding to the Zur box of the J96 hlyII operon was assessed as 
previously reported31. A fluorescence-labeled 50-bp fragment of the hlyII promoter containing the putative Zur 
binding site was prepared by annealing two single strand DNA oligos. An oligo with a 5′ end Cy5 label (5′-/5Cy5/
TCTTTATTTATTGTTTGTGTTATGTTATAACATATAAAAGAGTATTGTTT-3′) and its reversed complement 
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sequence with no labels (5′-AAACAATACTCTTTTATATGTTATAACATAACACAAACAATAAATAAAGA-3′) 
were ordered from Integrated DNA Technologies (IDT). To make double stranded DNA, oligos were dissolved 
in the annealing buffer (10 mM Tris, 1 mM EDTA, 50 mM NaCl, pH 7.5), incubated at 95 oC for 5 min and slowly 
cooled to room temperature. 60 pM of DNA and various concentrations of the wild-type Zur protein (from E. 
coli MG1655) was mixed in the binding buffer (10 mM Tris, 10 mM NaCl, pH 8.0) containing 2 mM MgCl2, 1 mM 
CaCl2, 166 mM KCl, 100 mM L-potassium glutamic acid, 100 µg/mL bovine serum albumin (BSA), 2 µg/mL soni-
cated salmon sperm DNA, 5 mM DTT, 50 µM ZnSO4, 5% glycerol. DNA-protein mixtures were incubated at room 
temperature shielded from light for 30 minutes. The purity of the Zur protein used is shown in Fig. S5. In all Zur/
DNA binding assays, protein samples were equilibrated with operator DNA with addition of excess non-specific 
competitor DNA (i.e. salmon sperm DNA). This allows direct monitoring of specific protein-DNA interactions. 
Samples were then resolved in a 10% polyacrylamide (37.5:1 acrylamide:bisacrylamide) gel. Both gel and electro-
phoresis buffers contain 89 mM Tris (pH 8.0), 89 mM boric acid and 50 µM ZnSO4. Gels were run at 10 V/cm for 
60–70 minutes and visualized by Typhoon 9400 imager (GE Healthcare).
Statistical analysis. Analysis was carried out using R software. Unpaired t tests with p-values adjusted by 
Bonferroni’s method for multiple comparisons were used to make comparisons between two groups from a data 
set formed by several groups (i.e. cell detachment and cytolysis data). One-way analysis of variance (ANOVA) with 
Tukey’s multiple comparisons test was used for comparison of a data set formed by more than two groups (i.e. com-
plementation assay). Two-way ANOVA was used to compare a data set with two variables (i.e. hlyII expression in 
several genotypes under different zinc concentrations). A value of P < 0.05 was considered statistically significant.
Data availability. All data generated or analyzed during this study are included in this published article (and 
its Supplementary Information files).
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